文献速递慢病防控与筛查免疫规划传染病防控与疫情报告

美国慢性病患者对病毒性呼吸道感染疫苗与抗病毒药物的态度调查

Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions.
PubMed 文献 · Vaccine · 2026-02-20

该横断面在线调查于2025年3月31日至4月18日纳入3024名自报患有慢性呼吸系统疾病、心脏病或糖尿病的美国成人,评估其对病毒性呼吸道感染(VRI)疫苗和抗病毒药物的态度。多数参与者认为自身慢性病增加VRI风险,约半数曾使用处方抗病毒药,68%每年接种流感疫苗、64%接种新冠疫苗/加强针,总体态度积极。

要点

  • 68%参与者每年接种流感疫苗,64%接种新冠疫苗/加强针
  • 48%曾用处方抗病毒药预防疾病,60%若医生提供则愿意使用
  • 认为慢性病增加VRI风险者更可能接种推荐疫苗

核心结论

  • 该调查人群对VRI预防措施总体态度积极,提高患者对VRI风险认知可能增加预防干预接受度。

研究设计与样本

  • 横断面匿名在线调查,于2025年3月31日至4月18日开展,纳入3024名≥18岁自报患有慢性呼吸系统疾病、心脏病或糖尿病的美国成人。

主要发现

  • 60%参与者认为慢性健康问题增加VRI或其并发症风险。
  • 48%参与者曾服用处方抗病毒药预防生病,60%表示若医疗提供者提供则可能或非常可能服用。
  • 68%参与者每年接种流感疫苗,64%接种新冠疫苗/加强针。
  • 频繁因VRI出现严重并发症(如住院)者比住院较少者更可能曾服用处方抗病毒药。
  • 认为慢性病增加VRI风险者更可能接种推荐疫苗。

临床怎么用

  • 对慢性呼吸系统疾病、心脏病或糖尿病患者,应加强VRI风险沟通以提升疫苗和抗病毒药物接受度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with chronic respiratory disease, heart disease, or diabetes are highly susceptible to complications from viral respiratory infections (VRI). This survey aimed to gain insight into the attitudes toward vaccines and antivirals for VRI among adults in the US with these conditions. METHODS: This cross-sectional anonymous online survey was conducted from March 31-April 18, 2025. Individuals ≥18 years living in the US with a self-reported diagnosis of chronic respiratory disease, heart disease, or diabetes were eligible to participate. RESULTS: Of the 3024 survey participants, most (60%) participants felt their chronic health condition put them at increased risk of VRI or their complications. Approximately half (48%) of participants had ever taken a prescription antiviral to prevent getting sick and 60% reported that they would be likely or very likely to take a prescription antiviral if their healthcare provider offered it. The majority (68%) of participants received a yearly influenza vaccination and 64% received a COVID-19 vaccine/booster. Opinions about vaccines were overall favorable. Participants who frequently had serious complications (i.e., hospitalization) with VRI were more likely to have taken prescription antivirals than those with less frequent hospitalizations. Participants who felt that their chronic health condition put them at increased risk of VRI or their complications were more likely to have received recommended vaccinations. CONCLUSIONS: Attitudes toward VRI prevention were overall favorable in this survey population. Improving patient understanding of VRI-related risk may increase acceptance of prophylactic interventions among individuals with chronic health conditions.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tal-Singer R, McCreary G, Luttmann M, et al. Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions. Vaccine. 2026. PMID: 41722534. doi:10.1016/j.vaccine.2026.128384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。